➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Merck
Boehringer Ingelheim
Johnson and Johnson
Express Scripts

Last Updated: October 26, 2021

DrugPatentWatch Database Preview

Patent: 8,853,412

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Summary for Patent: 8,853,412
Title:Pyrrolidinone derivatives as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
Abstract: The present invention relates to pyrrolidinone derivatives. The pyrrolidinone derivatives are GPR119 modulators and useful for the prevention and/or treatment of diabetes, obesity, dyslipidemia and related disorders. The invention furthermore relates to the use of pyrrolidinone derivatives as active ingredients in pharmaceuticals, and pharmaceutical compositions comprising them.
Inventor(s): Schwink; Lothar (Frankfurt am Main, DE), Bossart; Martin (Frankfurt am Main, DE), Glombik; Heiner (Frankfurt am Main, DE), Gossel; Matthias (Frankfurt am Main, DE), Kadereit; Dieter (Frankfurt am Main, DE), Klabunde; Thomas (Frankfurt am Main, DE), Maier; Thomas (Frankfurt am Main, DE), Stengelin; Siegfried (Frankfurt am Main, DE)
Assignee: Sanofi (Paris, FR)
Application Number:14/048,425
Patent Claims:see list of patent claims

Details for Patent 8,853,412

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Amryt Pharmaceuticals Dac MYALEPT metreleptin For Injection 125390 2014-02-24 ⤷  Free Forever Trial 2032-10-09
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
McKinsey
Dow
Colorcon
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.